Food and Drug Administration

Pspychopharmacologic Drugs Advisory Committee

and the

Pediatric Advisory Committee

September 14, 2004

Slides

Summary Comments on Antidepressants and Suicidality in Pediatric Patients & Questions/Topics for Comment, Dr. Thomas Laughren, MD, FDA (HTM) (PPT)

Recent Observational Studies of Antidepressants (ADs) and Suicidal Behavior, Dr. Diane Wysowski, PhD, FDA (HTM) (PPT)